These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3000257)

  • 1. Role of adenosine deaminase in human monocyte differentiation and tumor cell cytotoxicity.
    Kaplan AM; Gerrard TL; Strawson J; Squire C; Aultman M
    Ann N Y Acad Sci; 1985; 451():264-78. PubMed ID: 3000257
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of adenosine deaminase in the early stages of precursor T cell maturation.
    Shore A; Dosch HM; Gelfand EW
    Clin Exp Immunol; 1981 Apr; 44(1):152-5. PubMed ID: 6973431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for adenosine deaminase in human monocyte maturation.
    Fischer D; Van der Weyden MB; Snyderman R; Kelley WN
    J Clin Invest; 1976 Aug; 58(2):399-407. PubMed ID: 956374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase and immunodeficiency: an in vitro model.
    Hirschhorn R; Sela E
    Cell Immunol; 1977 Aug; 32(2):350-60. PubMed ID: 902324
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes.
    Johnston JM; Kredich NM
    J Immunol; 1979 Jul; 123(1):97-103. PubMed ID: 448160
    [No Abstract]   [Full Text] [Related]  

  • 6. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide levels and mechanism of inhibition of leucocyte function by adenosine deaminase inhibition.
    Meisel AD; Natarajan C; Sterba G; Diamond HS
    Adv Exp Med Biol; 1979; 122B():251-7. PubMed ID: 232632
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
    Wolberg G; Zimmerman TP
    Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminase impairment and ribonucleotide reductase in human cells.
    Elford HL; Lin AL
    Ann N Y Acad Sci; 1985; 451():98-112. PubMed ID: 3907454
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine deaminase activity in patients with carcinoma of the bladder.
    Sufrin G; Tritsch GL; Mittelman A; Murphy GP
    J Urol; 1978 Mar; 119(3):343-6. PubMed ID: 642089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].
    Lucivero G; Dammacco F; Bonomo L
    Recenti Prog Med; 1977 Sep; 63(3):275-88. PubMed ID: 413174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inside view of lymphocyte differentiation].
    Thomas G
    Biochimie; 1982 Jan; 64(1):IX-XV. PubMed ID: 6802186
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
    Lapi L; Cohen SS
    Biochem Pharmacol; 1977 Jan; 26(1):71-6. PubMed ID: 299815
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency.
    Hershfield MS; Kurtzberg J; Aiyar VN; Suh EJ; Schiff R
    Ann N Y Acad Sci; 1985; 451():78-86. PubMed ID: 3865575
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of antibody production by 2-chloroadenosine.
    Samet MK
    Life Sci; 1985 Jul; 37(3):225-33. PubMed ID: 3874340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exogenous adenosine deaminase and erythro-9-(2-hydroxy-3-nonyl) adenine on intracellular cyclic AMP levels in C1300 murine neuroblastoma in tissue culture.
    Green RD
    Life Sci; 1980 Feb; 26(5):399-406. PubMed ID: 6245318
    [No Abstract]   [Full Text] [Related]  

  • 19. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
    Chan TS
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adenosine deaminase in lymphocyte proliferation.
    Hovi T; Smyth JF; Allison AC; Williams SC
    Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.